MX2016017000A - Concoction composition in the form of a soft capsule with liquid content. - Google Patents

Concoction composition in the form of a soft capsule with liquid content.

Info

Publication number
MX2016017000A
MX2016017000A MX2016017000A MX2016017000A MX2016017000A MX 2016017000 A MX2016017000 A MX 2016017000A MX 2016017000 A MX2016017000 A MX 2016017000A MX 2016017000 A MX2016017000 A MX 2016017000A MX 2016017000 A MX2016017000 A MX 2016017000A
Authority
MX
Mexico
Prior art keywords
composition
concoction
soft capsule
liquid content
capsule
Prior art date
Application number
MX2016017000A
Other languages
Spanish (es)
Inventor
Verduzco Chávez Luis
VERDUZCO KOLOFFON Luis
Berenice CHÁVEZ HERRERA Yeimy
Original Assignee
Gelpharma S A De C V
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gelpharma S A De C V filed Critical Gelpharma S A De C V
Priority to MX2016017000A priority Critical patent/MX2016017000A/en
Publication of MX2016017000A publication Critical patent/MX2016017000A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

The present disclosure is related to pharmaceutical compositions in liquid form contained in a capsule for oral administration, which comprises a non-steroidal anti-inflammatory; a proton pump inhibitor; a solubilizing agent comprising polyvidone, polyethylene glycol or propylene glycol; and a vehicle comprising ethyl alcohol or water. This composition is useful in the pain treatment related to osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, low back pain and primary dysmenorrhea.
MX2016017000A 2016-12-19 2016-12-19 Concoction composition in the form of a soft capsule with liquid content. MX2016017000A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MX2016017000A MX2016017000A (en) 2016-12-19 2016-12-19 Concoction composition in the form of a soft capsule with liquid content.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MX2016017000A MX2016017000A (en) 2016-12-19 2016-12-19 Concoction composition in the form of a soft capsule with liquid content.

Publications (1)

Publication Number Publication Date
MX2016017000A true MX2016017000A (en) 2018-06-18

Family

ID=63361749

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2016017000A MX2016017000A (en) 2016-12-19 2016-12-19 Concoction composition in the form of a soft capsule with liquid content.

Country Status (1)

Country Link
MX (1) MX2016017000A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020096441A1 (en) * 2018-11-05 2020-05-14 AMEZCUA AMEZCUA, Federico Pharmaceutical composition which comprises the combination of a selective inhibitor of cyclooxygenase 2 and a carbamate derived from guaifenesin for treating pain, inflammation and muscular contraction

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020096441A1 (en) * 2018-11-05 2020-05-14 AMEZCUA AMEZCUA, Federico Pharmaceutical composition which comprises the combination of a selective inhibitor of cyclooxygenase 2 and a carbamate derived from guaifenesin for treating pain, inflammation and muscular contraction

Similar Documents

Publication Publication Date Title
MX2021006035A (en) Stable cannabinoid formulations.
CR20210061A (en) Pharmaceutical compositions comprising meloxicam
MX2021014509A (en) Pharmaceutical compositions comprising meloxicam.
EP4306168A3 (en) Isoxazoline compositions and use thereof in the prevention or treatment of parasite infestations in animals
NZ709958A (en) Enhanced stability of novel liquid compositions
CL2017000984A1 (en) Reduction of the viscosity of pharmaceutical formulations
EA202091318A1 (en) A PREPARATION CONTAINING GROUP B ADENOVIRUS
NZ752750A (en) Stable aqueous capsaicin injectable formulations and medical uses thereof
EA201692392A1 (en) NEW MEDICINE FORM OF MELOXYCAM
MX2022013566A (en) Antibody.
EA201790223A1 (en) WATER PREPARATION CONTAINING PARACETAMOL AND IBUPROFEN
EA202192322A1 (en) PHARMACEUTICAL COMPOSITIONS
AR118365A1 (en) DRINK APPLICATOR AND DEVICE FOR ORAL ADMINISTRATION OF AN INGERIBLE OBJECT TO A PATIENT
MX2016017000A (en) Concoction composition in the form of a soft capsule with liquid content.
MX2019002921A (en) Oral care compositions and dispensing system therefor.
CL2016003131A1 (en) Omega-3 compositions, dosage forms, and methods of use
WO2016075704A3 (en) Stable topical pharmaceutical compositions comprising gabapentin
NZ722830A (en) Topical formulations of heparin
AR109503A1 (en) PHARMACEUTICAL COMPOSITION THAT INCLUDES (E) -2,4,6-TRIMETOXIESTIRIL-3 - [(CARBOXIMETHYL) AMINO] -4-METOXIBENCILSULFONA, ORAL DOSING FORM AND TREATMENT METHOD
MX2020002606A (en) Medroxyprogesterone acetate injectable compositions and methods of use.
RU2017140779A (en) COMPOSITIONS FOR CANCER TREATMENT
MX2013009849A (en) Capsule with liquid content including an anti-inflammatory.
AR100153A1 (en) MEDICINE
PH12019501049A1 (en) Pharmaceutical composition containing palonosetron as active ingredient
CO2019013645A2 (en) Dropropizine in combination with ambroxol in the dosage form of syrup and tablets